We are live on ! Find out more
GIP

Greatmark Investment Partners Portfolio holdings

AUM $906M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.56%
AUM
$276M
AUM Growth
+$14.6M
Cap. Flow
-$9.35M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.22%
Holding
122
New
8
Increased
15
Reduced
72
Closed
3

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$929K
2
AFL icon
Aflac
AFL
+$820K
3
ESV
Ensco Rowan plc
ESV
+$763K
4
JNJ icon
Johnson & Johnson
JNJ
+$722K
5
PAYX icon
Paychex
PAYX
+$673K

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Financials 19.97%
3 Healthcare 13.75%
4 Industrials 10.66%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
1
Aflac
AFL
$63.9B
$17.1M 6.21%
390,156
-19,202
-5% -$820K
AAPL icon
2
Apple
AAPL
$4.89T
$14.3M 5.17%
337,180
-15,640
-4% -$654K
MSFT icon
3
Microsoft
MSFT
$2.84T
$13.3M 4.81%
155,038
-7,891
-5% -$647K
INTC icon
4
Intel
INTC
$466B
$11.7M 4.23%
252,614
-12,017
-5% -$524K
JNJ icon
5
Johnson & Johnson
JNJ
$635B
$9.9M 3.59%
70,881
-5,180
-7% -$722K
CSCO icon
6
Cisco
CSCO
$450B
$9.25M 3.35%
241,495
-8,462
-3% -$302K
HD icon
7
Home Depot
HD
$332B
$8.4M 3.04%
44,302
-2,509
-5% -$433K
AXP icon
8
American Express
AXP
$223B
$8.29M 3%
83,458
-4,630
-5% -$441K
BAC icon
9
Bank of America
BAC
$435B
$8.07M 2.92%
273,353
-4,590
-2% -$127K
QCOM icon
10
Qualcomm
QCOM
$176B
$7.99M 2.9%
124,794
-1,345
-1% -$81.6K
KSS icon
11
Kohl's
KSS
$2.03B
$7.39M 2.68%
136,325
-4,725
-3% -$217K
ITW icon
12
Illinois Tool Works
ITW
$81.4B
$7.35M 2.66%
44,061
-1,330
-3% -$212K
KO icon
13
Coca-Cola
KO
$354B
$6.59M 2.39%
143,632
-1,825
-1% -$83.9K
UPS icon
14
United Parcel Service
UPS
$97.6B
$6.43M 2.33%
53,991
-1,957
-3% -$230K
TGT icon
15
Target
TGT
$62.1B
$6.33M 2.3%
97,080
-3,330
-3% -$201K
GILD icon
16
Gilead Sciences
GILD
$161B
$5.54M 2.01%
77,304
+2,009
+3% +$153K
EMR icon
17
Emerson Electric
EMR
$82.9B
$5.2M 1.89%
74,663
-2,784
-4% -$180K
GWW icon
18
W.W. Grainger
GWW
$65.3B
$5.16M 1.87%
21,855
-85
-0.4% -$17.6K
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
$5.15M 1.87%
68,940
-8,810
-11% -$563K
TEVA icon
20
Teva Pharmaceuticals
TEVA
$35.9B
$4.98M 1.8%
262,575
-61,759
-19% -$929K
WFC icon
21
Wells Fargo
WFC
$261B
$4.82M 1.75%
79,371
-2,545
-3% -$144K
CVX icon
22
Chevron
CVX
$388B
$4.12M 1.49%
32,914
-469
-1% -$55.6K
LOW icon
23
Lowe's Companies
LOW
$116B
$3.9M 1.41%
41,905
+22,645
+118% +$1.87M
CHY
24
Calamos Convertible and High Income Fund
CHY
$1.03B
$3.84M 1.39%
323,825
+7,486
+2% +$88.9K
ELV icon
25
Elevance Health
ELV
$81.9B
$3.79M 1.37%
16,852
-1,387
-8% -$295K

Similar funds

Greatmark Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Greatmark Investment Partners held 122 positions worth $276M, up 5.6% from $261M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Greatmark Investment Partners withdrew a net $9.35M in Q4 2017, closing 3 positions and reducing 72 holdings. Its most notable exit was Verizon, an estimated $249K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Greatmark Investment Partners opened a new position in Lumen worth $1.19M.

  • Greatmark Investment Partners's largest Q4 2017 buy was Lumen: 71,575 shares worth $1.19M.
  • Greatmark Investment Partners added most to Lowe's Companies in Q4 2017, an estimated $1.87M increase.
  • Greatmark Investment Partners's biggest Q4 2017 reduction was Teva Pharmaceuticals, cutting an estimated $929K.
  • Greatmark Investment Partners fully exited Verizon in Q4 2017, selling an estimated $249K.
  • Greatmark Investment Partners's ten largest holdings make up 39% of its $276M portfolio in Q4 2017.
  • Greatmark Investment Partners opened 8 new positions and closed 3 in Q4 2017.
  • Greatmark Investment Partners's portfolio value rose 5.6% quarter-over-quarter to $276M.

Based on Greatmark Investment Partners's 13F filing for Q4 2017, filed 1 Feb 2018.